| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |